This trial is examining the efficacy of two treatment protocols for improving cognitive performance in people with spinal cord injuries, compared to placebo. The treatment protocols involve midodrine hydrochloride (an alpha agonist) and cognitive behavior therapy. The study will use neuropsychological and global functioning assessments to evaluate the impact of the treatment on memory performance and everyday life activities, respectively. The investigators will also evaluate the long-term efficacy of the treatment by including a 6-month post-treatment follow-up.
1 Primary · 3 Secondary · Reporting Duration: Screening (before baseline measures), Baseline, Immediate Follow-up (about 2 months after baseline), Long-term Follow-up (6 months after immediate follow-up)
104 Total Participants · 4 Treatment Groups
Primary Treatment: SPT · No Placebo Group · N/A
Age 18 - 75 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: